- Home
- RVPHW vs HOVNP Comparison
RVPHW vs HOVNP Comparison
Compare RVPHW & HOVNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- HOVNP
- Stock Information
- Founded
- RVPHW 2018
- HOVNP N/A
- Country
- RVPHW United States
- HOVNP United States
- Employees
- RVPHW N/A
- HOVNP 1878
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- HOVNP Homebuilding
- Sector
- RVPHW Health Care
- HOVNP Consumer Discretionary
- Exchange
- RVPHW Nasdaq
- HOVNP Nasdaq
- Market Cap
- RVPHW N/A
- HOVNP N/A
- IPO Year
- RVPHW N/A
- HOVNP N/A
- Fundamental
- Price
- RVPHW $0.06
- HOVNP $17.19
- Analyst Decision
- RVPHW
- HOVNP
- Analyst Count
- RVPHW 0
- HOVNP 0
- Target Price
- RVPHW N/A
- HOVNP N/A
- AVG Volume (30 Days)
- RVPHW 22.4K
- HOVNP N/A
- Earning Date
- RVPHW 03-14-2025
- HOVNP N/A
- Dividend Yield
- RVPHW N/A
- HOVNP N/A
- EPS Growth
- RVPHW N/A
- HOVNP N/A
- EPS
- RVPHW N/A
- HOVNP N/A
- Revenue
- RVPHW N/A
- HOVNP N/A
- Revenue This Year
- RVPHW N/A
- HOVNP N/A
- Revenue Next Year
- RVPHW N/A
- HOVNP N/A
- P/E Ratio
- RVPHW N/A
- HOVNP N/A
- Revenue Growth
- RVPHW N/A
- HOVNP N/A
- 52 Week Low
- RVPHW $0.13
- HOVNP N/A
- 52 Week High
- RVPHW $0.15
- HOVNP N/A
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- HOVNP 53.34
- Support Level
- RVPHW N/A
- HOVNP $17.10
- Resistance Level
- RVPHW N/A
- HOVNP $17.45
- Average True Range (ATR)
- RVPHW 0.00
- HOVNP 0.21
- MACD
- RVPHW 0.00
- HOVNP 0.02
- Stochastic Oscillator
- RVPHW 0.00
- HOVNP 74.47
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About HOVNP Hovnanian Enterprises Inc Dep Shr Srs A Pfd
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.